Seattle based, Adaptive Biotechnologies, has filed for a $230 Million IPO. The company currently offers tools for monitoring several cancer types, sequencing immune system components, and aiding drug discovery. The filing does not yet specify the number of shares to be offered. Adaptive has filed to trade on NASDAQ under the symbol, "ADPT."
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,